Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Abu Salim Mustafa. (2009) Vaccine potential of Mycobacterium tuberculosis-specific genomic regions: in vitro studies in humans. Expert Review of Vaccines 8:10, pages 1309-1312.
Read now
Read now
Arvind K Bansal. (2008) Role of bioinformatics in the development of new antibacterial therapy. Expert Review of Anti-infective Therapy 6:1, pages 51-65.
Read now
Read now
Regina C LaRocque, Jason B Harris, Edward T Ryan, Firdausi Qadri & Stephen B Calderwood. (2006) Postgenomic approaches to cholera vaccine development. Expert Review of Vaccines 5:3, pages 337-346.
Read now
Read now
Articles from other publishers (15)
Huichang Huang, Feifei Wang, Enzhuo Yang, Honghai Wang, Peng Gao & Hongbo Shen. (2018) Assessment of recombinant plasmid expressing fusion antigen Ag85B-Rv3425 in management of acute tuberculosis infection in mice. Experimental and Therapeutic Medicine.
Crossref
Crossref
Shen-An Hwang, Marian L Kruzel & Jeffrey K Actor. (2015) CHO expressed recombinant human lactoferrin as an adjuvant for BCG. International Journal of Immunopathology and Pharmacology 28:4, pages 452-468.
Crossref
Crossref
. (2015) Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014. Vaccine 33:26, pages 3047-3055.
Crossref
Crossref
Ashley M. McMullen, Shen-An Hwang, Kelly O'Shea, Maureen L. Aliru & Jeffrey K. Actor. (2013) Evidence for a unique species-specific hypersensitive epitope in Mycobacterium tuberculosis derived cord factor. Tuberculosis 93, pages S88-S93.
Crossref
Crossref
Abu Salim Mustafa. (2013) In silico Analysis and Experimental Validation of <b><i>Mycobacterium tuberculosis</i></b>-Specific Proteins and Peptides of <b><i>Mycobacterium tuberculosis</i></b> for Immunological Diagnosis and Vaccine Development. Medical Principles and Practice 22:Suppl. 1, pages 43-51.
Crossref
Crossref
Alan R. Shaw & Mark B. Feinberg. 2013. Clinical Immunology. Clinical Immunology
1095
1121
.
Wei Yuan, Na Dong, Lifang Zhang, Jiangning Liu, Shuzhu Lin, Zhiguang Xiang, Hongwei Qiao, Wei Tong & Chuan Qin. (2012) Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Vaccine 30:14, pages 2490-2497.
Crossref
Crossref
Markos Abebe, Louise Kim, Graham Rook, Abraham Aseffa, Liya Wassie, Martha Zewdie, Alimuddin Zumla, Howard Engers, Peter Andersen & T. Mark Doherty. (2011)
Modulation of Cell Death by
M. tuberculosis
as a Strategy for Pathogen Survival
. Clinical and Developmental Immunology 2011, pages 1-11.
Crossref
Crossref
K.B. Walker, M.J. Brennan, M.M. Ho, J. Eskola, G. Thiry, J. Sadoff, R. Dobbelaer, L. Grode, M.A. Liu, U. Fruth & P.H. Lambert. (2010) The second Geneva Consensus: Recommendations for novel live TB vaccines. Vaccine 28:11, pages 2259-2270.
Crossref
Crossref
Haifeng Gao, Yan Yue, Linkun Hu, Wei Xu & Sidong Xiong. (2009) A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge. Vaccine 27:39, pages 5313-5319.
Crossref
Crossref
JES DIETRICH & T. MARK DOHERTY. (2009)
Interaction of
Mycobacterium tuberculosis
with the host: consequences for vaccine development
. APMIS 117:5-6, pages 440-457.
Crossref
Crossref
G.M. Scandurra, W.J. Britton & J.A. Triccas. (2008) Inactivation of the Mycobacterium tuberculosis fadB4 gene results in increased virulence in host cell and mice. Microbes and Infection 10:1, pages 38-44.
Crossref
Crossref
Alan R. Shaw & Mark B. Feinberg. 2008. Clinical Immunology. Clinical Immunology
1353
1382
.
Vasan K. Sambandamurthy, Steven C. Derrick, Tsungda Hsu, Bing Chen, Michelle H. Larsen, Kripa V. Jalapathy, Mei Chen, John Kim, Steven A. Porcelli, John Chan, Sheldon L. Morris & William R. JacobsJr.Jr.. (2006) Mycobacterium tuberculosis ΔRD1 ΔpanCD: A safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine 24:37-39, pages 6309-6320.
Crossref
Crossref
Caroline Demangel & Roland Brosch. (2006) Apports de la génomique des mycobactéries a la définition de nouvelles stratégies thérapeutiques et vaccinales anti-tuberculeuses. Revue Francophone des Laboratoires 2006:381, pages 23-30.
Crossref
Crossref